Price target upside
Immuneering Corporation - Class A Common Stock Price Target Upside or Downside
IMRX price target upside based on the current price and analyst average.
Direct answer
Immuneering Corporation - Class A Common Stock's analyst target implies +280.2%.
The average target is $18.25 compared with a recorded current price of $4.80.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Immuneering Corporation - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.80
- Average price target
- $18.25
- High price target
- $30.00
- Low price target
- $12.00
- Target upside
- +280.2%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026